Aptose Biosciences (APTOF) Revenue by Year
Aptose Biosciences Inc generated $0 in revenue in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $0 in revenue. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Aptose Biosciences Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
APTOF Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
APTOF Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Aptose Biosciences Inc financials
Frequently Asked Questions
Aptose Biosciences Inc generated $0 in revenue in fiscal year 2025.
Aptose Biosciences Inc (APTOF) reported $0 in revenue in fiscal year 2024 and $0 in revenue in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Aptose Biosciences Inc (APTOF) reported $0 in revenue over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
Aptose Biosciences Inc (APTOF) reported $0 in revenue in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Aptose Biosciences Inc (APTOF) reported on that line in every period on record.